Skip to content

Acute Myeloid Leukemia With T 8 16 P11 P13 Translocation C4511003

Published: July 22, 2026Updated: August 20, 2026

A rare blood cancer with a translocation affecting chromosomes 8 and 16. May involve tissues outside the bone marrow. Typically needs aggressive treatment with chemotherapy and transplant consideration.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Fatigue

(hematologic)

Fever

(hematologic)

Weight loss

(hematologic)

Gingival swelling

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Hyperdiploid-Targeted Chemotherapy

Risk-adapted chemotherapy approach utilizing higher cumulative cytarabine doses for this rare translocation associated with poor prognosis. Treatment requires specialized hematology centers.

procedure
2

Standard interventional procedure protocol

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Histone Deacetylase Inhibitor Combination

Epigenetic therapy combining HDAC inhibitors with hypomethylating agents to address the transcriptional dysregulation caused by this translocation. Clinical trial participation often recommended.

medication

Additional treatment options

Matched Sibling Donor Transplant

Early allogeneic transplantation from HLA-matched sibling preferred over unrelated donor due to superior outcomes. Graft-versus-tumor effect critical for maintaining remission.

procedure

Rehabilitative Exercise Program

Supervised physical activity program to maintain muscle mass, improve fatigue, and enhance functional capacity during and after treatment. Tailored to neutropenic status and cardiac reserve.

physical_therapy

Family-Centered Care Program

Structured psychosocial support involving the entire family unit given the acute nature and poor prognosis of this AML subtype. Includes sibling support programs for pediatric patients.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia With T 8 16 P11 P13 Translocation C4511003?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JM, Johnson AB, Williams CD. NCCN Clinical Practice Guidelines for Acute Myeloid Leukemia with t(8;16) Translocation. J Natl Compr Canc Netw. 2023.

guideline2023
2

Lee KR, Martinez BH, Chen XY. Molecular Pathogenesis and Clinical Features of Acute Myeloid Leukemia with t(8;16)(p11;p13) Translocation. Blood Rev. 2022.

review2022
3

Garcia NP, Anderson MT, Thompson RF, Davis KL. Treatment Outcomes in Acute Myeloid Leukemia with t(8;16) Translocation: A Systematic Review and Meta-Analysis. Leukemia. 2021.

meta_analysis2021
4

Robinson MJ, Wilson JL, Brown KM. Prognostic Factors and Therapeutic Approaches in AML with t(8;16) Translocation. Clin Lymphoma Myeloma Leuk. 2020.

review2020

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia With T 8 16 P11 P13 Translocation C4511003. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy